Access DEA Events History 
NORML
OCTOBER 21, 2019
Justices for the US Court of Appeals for the District of Columbia denied the petition following a filing by DEA in the Federal Register stating that the agency “intends to promulgate regulations” to review several dozen federal cultivation applications.
WeedAdvisor
JUNE 1, 2019
In a rather surprising turn of events, a federal appeals court gave marijuana advocates a small opening in their ongoing battle to reschedule marijuana, according to Marijuana Moment. The court, citing concerns over marijuana’s Schedule I status and its impact on medical users who need it most, essentially issued an ultimatum to the DEA.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JUNE 15, 2019
The conference raises numerous questions related to securities laws, the access to capital markets by cannabis industry companies prior to the removal of cannabis from the Controlled Substances Act [“CSA”] by the DEA or Congress, and the level of scrutiny that both public companies and individual investors can expect. FBI Director J.
Canna Law Blog
OCTOBER 29, 2019
Plans must also ensure that samples are representative of an entire hemp lot and the state or tribal agency charged with testing must have unrestricted access to all land, building, and structures used for the cultivation, handling, and storage of hemp. Applicants must submit their contact information and a criminal history report.
Cannabis Law Report
SEPTEMBER 23, 2019
Cannabis use, both medically and recreationally, is prevalent throughout history. Surveying marijuana use is essential to gauge public health implications of increased access to marijuana, cannabinoid, and cannabis products. Background. Extensive evidence. 1 In the U.S. and 2.3%, respectively. 48 Incarceration impacts health.
Cannabis Law Report
JUNE 1, 2021
A replay will be accessible by webcast until 11:59 PM ET on August 30, 2021 at: [link]. Drug Enforcement Administration (the “DEA”), the U.S. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking statements.
Cannabis Law Report
APRIL 8, 2022
To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history. Later that year, Doblin sued the DEA for the first time. submitted his first DEA application to manufacture marijuana for use in medical research. Lyle Craker, Ph.D., MAPS Founder Rick Doblin, Ph.D.,
Expert insights. Personalized for you.
103 
Let's personalize your content